Immunotherapy biomarker discovery could benefit thousands with Type 1 diabetes

diabetes
Credit: CC0 Public Domain

Scientists at UCL have discovered new biomarkers, which may identify those people with Type 1 diabetes who would benefit from the immunotherapy drug Abatacept, a finding which could eventually help thousands manage the disease more effectively.

Type 1 diabetes is an autoimmune…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *